Demographic, clinical and treatment patterns of patients with heart failure with reduced ejection fraction (HFrEF) in the Australian primary care setting

Back

ESC2025 Premium Access

Demographic, clinical and treatment patterns of patients with heart failure with reduced ejection fraction (HFrEF) in the Australian primary care setting

Session: Heart failure therapies: current drug strategies

Topic: Pharmacotherapy

Speaker: Associate Professor A. Nelson (Melbourne, AU)

Event: ESC Congress 2025

Congress Presentation

Add to my library

About the speaker

Associate Professor Adam James Nelson

VICTORIAN HEART HOSPITAL, Melbourne (Australia)

2 presentations

0 follower

6 more presentations in this session

GLP-1 receptor agonists for obesity-related heart failure with preserved ejection fraction: a systematic review and meta-analysis of randomized controlled trials

Speaker: Mr C. Rodrigues Rosa (Belo Horizonte, BR)

Targeting the HIF-1/ASC pathway with dapagliflozin protects against sleep apnea-exacerbated myocardial damage in heart failure

Speaker: Doctor L. Xie (Nanjing, CN)

Access

Abstract

Slides

Levosimendan in advanced heart failure: a step forward in functional recovery and hospitalization reduction

Speaker: Doctor F. Gerardo (Amadora, PT)

Early exercise-based rehabilitation for patients with acute decompensated heart failure: an updated systematic review and meta-analysis

Speaker: Mr D. Abraham (Manaus, BR)

SGLT2 inhibitor therapy in patients with acute Takotsubo syndrome

Speaker: Doctor L. Arcari (Rome, IT)

Access the full session

Heart failure therapies: current drug strategies

Speakers: Associate Professor A. Nelson, Mr C. Rodrigues Rosa, Doctor L. Xie, Doctor F. Gerardo, Mr D. Abraham...

Access

About the event

ESC Congress 2025

29 August - 1 September 2025

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources

Explore sponsored resources